title: Independent and combined effects of ethanol self-administration and nicotine treatment on hepatic CYP2E1 in African green monkeys.
abstract: Cytochrome P450 2E1 metabolizes ethanol and also bioactivates many toxins and procarcinogens. Elevated levels of hepatic CYP2E1 are associated with an increased susceptibility to chemical toxicity and carcinogenesis. This study investigated the induction of hepatic CYP2E1 by ethanol and nicotine, alone and in combination, in a nonhuman primate model. Monkeys that self-administered ethanol and that received subcutaneous injections of nicotine (0.5 mg/kg b.i.d.), alone and in combination, were compared with control animals (four groups, n = 10/group). Chlorzoxazone (CZN) was used as a probe drug to phenotype in vivo CYP2E1 activity before and after chronic ethanol and/or nicotine exposure. CYP2E1 protein levels and in vitro chlorzoxazone metabolism were assessed in liver microsomes. Average daily ethanol consumption was ≈3.0 g/kg (blood ethanol levels ≈24 mM) and was unaffected by nicotine treatment. Ethanol self-administration and nicotine treatment, alone and in combination, significantly increased in vivo CZN disposition compared with that in control animals. The effect of ethanol was only observed at higher levels of intake. Ethanol and nicotine increased CYP2E1 protein levels and in vitro CZN metabolism, with combined exposure to both drugs resulting in the greatest increase. The effect of ethanol was also dependent on level of intake. Chronic exposure to ethanol and nicotine induced hepatic CYP2E1 activity and protein levels, particularly when both drugs were used in combination and when ethanol intake was high. These results have important implications for public health, given the association between elevated CYP2E1 and disease, and the large proportion of individuals who are exposed to ethanol and nicotine, often in combination.
authors.affiliation: Centre for Addiction and Mental Health, University of Toronto, Ontario, Canada.
authors.forename: C S
authors.initials: CS
authors.lastname: Ferguson
authors.forename: S
authors.initials: S
authors.lastname: Miksys
authors.forename: R
authors.initials: R
authors.lastname: Palmour
authors.forename: R F
authors.initials: RF
authors.lastname: Tyndale
mesh_terms: D000818:Animals; D001483:Base Sequence; D002522:Chlorocebus aethiops; D019392:Cytochrome P-450 CYP2E1 / Q000378:metabolism*; D017931:DNA Primers; D000431:Ethanol / Q000008:administration & dosage* / Q000494:pharmacology; D008297:Male; D008862:Microsomes, Liver / Q000187:drug effects* / Q000201:enzymology; D009538:Nicotine / Q000008:administration & dosage*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012646:Self Administration
chemical_list: D017931:DNA Primers; D000431:Ethanol; D009538:Nicotine; D019392:Cytochrome P-450 CYP2E1